hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 10:05:25 - browse：1

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： A daunting task: navigating dual Medicare, Medicaid eligibility

WSS

Gain of function research would be limited under House proposal

Ransomware attacks on hospitals: Study outlines patient impact

Readout LOUD podcast: A CRISPR milestone, biotech mixology

U.K. considers world's first use of meningitis vaccine to address gonorrhea

A controversial new treatment promises to make little people taller

Congress must reauthorize a committee to support older Americans

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Weight loss drug costs may need more research, senator suggests

United colonoscopy coverage change 'may cost lives,' doctors say

A daunting task: navigating dual Medicare, Medicaid eligibility

Alkermes shareholders re

Gain of function research would be limited under House proposal

Malaria cases in Florida and Texas: Here’s what you need to know

FDA scientists endorse Pfizer/BioNTech Covid

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

explore

CRISPR pioneers react to Casgevy, first gene

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

NYU radiologists take on the challenge of expensive MRI machines

The cancer stories no one wants to hear

2 officers injured in shooting in Orlando, police say

knowledge

entertainment

hotspot

hotspot